Cargando…
Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature
Histone 3 lysine 27 (H3K27) demethylation constitutes an important epigenetic mechanism of gene activation. It is mediated by the Jumonji C domain-containing lysine demethylases KDM6A and KDM6B, both of which have been implicated in a wide myriad of diseases, including blood and solid tumours, autoi...
Autores principales: | Abu-Hanna, Jeries, Patel, Jigisha A., Anastasakis, Evangelos, Cohen, Richard, Clapp, Lucie H., Loizidou, Marilena, Eddama, Mohammad M. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344682/ https://www.ncbi.nlm.nih.gov/pubmed/35915507 http://dx.doi.org/10.1186/s13148-022-01305-8 |
Ejemplares similares
-
Contrasting roles for histone 3 lysine 27 demethylases in acute lymphoblastic leukemia
por: Ntziachristos, Panagiotis, et al.
Publicado: (2014) -
The role of microvesicles as biomarkers in the screening of colorectal neoplasm
por: Eddama, Mohammad M. R., et al.
Publicado: (2022) -
Histone lysine demethylases in Drosophila melanogaster
por: Holowatyj, Andreana, et al.
Publicado: (2015) -
Histone demethylase lysine demethylase 5B in development and cancer
por: Han, Mengjiao, et al.
Publicado: (2016) -
Histone lysine demethylases in mammalian embryonic development
por: Shen, Hongjie, et al.
Publicado: (2017)